Subbu Nambi
Stock Analyst at Guggenheim
(4.76)
# 592
Out of 4,442 analysts
157
Total ratings
62.6%
Success rate
25.6%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ILMN Illumina | Reiterated: Buy | $170 → $180 | $164.93 | +9.14% | 11 | Jun 1, 2026 | |
| TEM Tempus AI | Maintained: Buy | $60 | $48.61 | +23.43% | 9 | Jun 1, 2026 | |
| GH Guardant Health | Maintained: Buy | $135 | $130.83 | +3.19% | 14 | May 28, 2026 | |
| GRAL GRAIL | Reiterated: Buy | $75 | $61.11 | +22.73% | 11 | May 26, 2026 | |
| TWST Twist Bioscience | Maintained: Buy | $60 | $85.00 | -29.41% | 8 | May 22, 2026 | |
| BLLN BillionToOne | Reiterated: Buy | $100 → $120 | $104.28 | +15.07% | 5 | May 13, 2026 | |
| WAT Waters | Reiterated: Buy | $440 | $357.20 | +23.18% | 5 | May 11, 2026 | |
| MRVI Maravai LifeSciences Holdings | Maintained: Hold | n/a | $5.37 | - | 3 | May 11, 2026 | |
| PSNL Personalis | Maintained: Buy | $13 | $10.06 | +29.22% | 5 | May 7, 2026 | |
| CSTL Castle Biosciences | Maintained: Buy | $47 | $21.42 | +119.42% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 | $55.11 | -9.27% | 8 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $53.79 | -16.34% | 9 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $17.23 | +21.88% | 3 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $5.24 | +33.72% | 4 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $12 | $14.76 | -18.70% | 4 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $70 | $58.08 | +20.52% | 7 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.35 | +70.58% | 8 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $8.83 | +35.90% | 7 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $275 → $235 | $178.97 | +31.31% | 7 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $270 | $234.76 | +15.01% | 6 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $126.37 | - | 6 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.31 | - | 1 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $11.47 | - | 2 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $99.90 | - | 2 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €263.00 | $212.70 | +23.65% | 2 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $17.60 | +81.82% | 1 | Jul 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.63 | n/a | 2 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $31.87 | n/a | 2 | Feb 23, 2025 |
Illumina
Jun 1, 2026
Reiterated: Buy
Price Target: $170 → $180
Current: $164.93
Upside: +9.14%
Tempus AI
Jun 1, 2026
Maintained: Buy
Price Target: $60
Current: $48.61
Upside: +23.43%
Guardant Health
May 28, 2026
Maintained: Buy
Price Target: $135
Current: $130.83
Upside: +3.19%
GRAIL
May 26, 2026
Reiterated: Buy
Price Target: $75
Current: $61.11
Upside: +22.73%
Twist Bioscience
May 22, 2026
Maintained: Buy
Price Target: $60
Current: $85.00
Upside: -29.41%
BillionToOne
May 13, 2026
Reiterated: Buy
Price Target: $100 → $120
Current: $104.28
Upside: +15.07%
Waters
May 11, 2026
Reiterated: Buy
Price Target: $440
Current: $357.20
Upside: +23.18%
Maravai LifeSciences Holdings
May 11, 2026
Maintained: Hold
Price Target: n/a
Current: $5.37
Upside: -
Personalis
May 7, 2026
Maintained: Buy
Price Target: $13
Current: $10.06
Upside: +29.22%
Castle Biosciences
May 7, 2026
Maintained: Buy
Price Target: $47
Current: $21.42
Upside: +119.42%
May 6, 2026
Maintained: Buy
Price Target: $50
Current: $55.11
Upside: -9.27%
May 6, 2026
Reiterated: Buy
Price Target: $45
Current: $53.79
Upside: -16.34%
May 6, 2026
Reiterated: Buy
Price Target: $21
Current: $17.23
Upside: +21.88%
May 6, 2026
Reiterated: Buy
Price Target: $7
Current: $5.24
Upside: +33.72%
May 5, 2026
Maintained: Buy
Price Target: $10 → $12
Current: $14.76
Upside: -18.70%
May 4, 2026
Reiterated: Buy
Price Target: $100 → $70
Current: $58.08
Upside: +20.52%
Apr 28, 2026
Reiterated: Buy
Price Target: $4
Current: $2.35
Upside: +70.58%
Apr 27, 2026
Maintained: Buy
Price Target: $12
Current: $8.83
Upside: +35.90%
Apr 21, 2026
Reiterated: Buy
Price Target: $275 → $235
Current: $178.97
Upside: +31.31%
Feb 26, 2026
Reiterated: Buy
Price Target: $270
Current: $234.76
Upside: +15.01%
Feb 24, 2026
Maintained: Hold
Price Target: n/a
Current: $126.37
Upside: -
Feb 12, 2026
Maintained: Hold
Price Target: n/a
Current: $1.31
Upside: -
Oct 28, 2025
Maintained: Hold
Price Target: n/a
Current: $11.47
Upside: -
Oct 27, 2025
Reiterated: Hold
Price Target: n/a
Current: $99.90
Upside: -
Oct 16, 2025
Reiterated: Buy
Price Target: €263.00
Current: $212.70
Upside: +23.65%
Jul 13, 2025
Initiated Coverage: Buy
Price Target: $32
Current: $17.60
Upside: +81.82%
Apr 8, 2025
Downgraded: Hold
Price Target: n/a
Current: $4.63
Upside: n/a
Feb 23, 2025
Maintained: Hold
Price Target: n/a
Current: $31.87
Upside: n/a